Navigation Links
New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
Date:11/8/2007

First-of-its-kind procedure from Colorado-based company

DENVER, Nov. 8 /PRNewswire/ -- Regenerative Sciences, Inc., has launched its patent-pending Regenexx(TM) procedure, which uses a patient's own stem cells to regenerate bone and cartilage -- a welcome relief for the more than 20 million Americans who suffer from painful and debilitating orthopedic conditions.

"The Regenexx procedure is different from all other treatments available today," said Chris Centeno, M.D., creator of Regenexx and an international expert and specialist in musculoskeletal, spinal and neurological injury. "Prior to Regenexx, physicians were limited in what they could offer degenerative joint patients: surgery or life with pain. Now physicians have a new tool in their tool kit."

In sanctioned clinical trials, Regenexx has been demonstrated to be safe and regenerates normal healthy tissues. A patient's stem cells are extracted with a needle from the hip, grown in culture at a Rengerative Sciences lab and then re-implanted into the patient at a doctor's office with a "needle out, needle in" approach, which substantially reduces downtime for the patient.

Unlike joint replacement or micro fracture that require weeks or months of being on crutches and pain medicines, the Regenexx procedure has no downtime. Most patients return to normal activity within 24 hours of completing the procedure.

A published clinical trial was conducted with a 46-year-old woman who had a two-year history of knee pain that began after being kicked in the shin during a martial arts class. Bone marrow was drawn from the patient, and in the next nine days, the marrow was used to grow mesenchymal stem cells, which have the ability to grow into bone, cartilage and muscle tissues. The grown stem cells initially taken from the patient were injected into her knee once a week for the next three weeks. Three months after the procedure, the patient reported that her pain had essentially disappeared. A MRI confirmed that the defect on her femur had been reduced by one-third.

Repair of the degenerated or injured area usually takes place in two to three months, and many patients feel better in one to three months.

About Regenerative Sciences

Founded in 2006, Regenerative Sciences is the Denver-based developer of Regenexx(TM), a breakthrough non-surgical option for people suffering from various orthopedic disorders. Regenexx is a patent-pending procedure that uses a person's own stem cells and blood growth factors to regenerate bone and cartilage.

The physicians at Regenerative Sciences are dedicated to providing the option of non-surgical joint repair to their patients. Headquartered in Colorado, they focus on delivering high quality treatment for people suffering from these often debilitating diseases. Visit http://www.Regenexx.com to learn more about benefits, research and the Regenexx procedure.


'/>"/>
SOURCE Regenerative Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
2. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
3. UK junior doctors gaining less experience of common procedures
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Eligard(R) six-month formulation successfully completes European approval procedure
6. Smoking can harm the long-term effects of some oral surgery procedures
7. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
8. Study Shows Cosmetic Surgery on the Rise as Safety and Efficacy of Procedures Increase
9. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
10. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
11. Decrease in the use of radiotherapy procedures for the treatment of cancer in hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
Breaking Medicine Technology: